Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

34
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
34
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

19
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

26
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
26
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

35
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
35
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

23
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23
Inflammation01:38

Inflammation

54.4K
Overview
54.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Better care and improved outcomes if your patients are enrolled in a research programme.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Artificial Intelligence in Biomedical Scientific Publishing.

European heart journal·2026
Same author

Environmental risk factors and cardiovascular health.

European heart journal·2026
Same author

Implementation of quality of care in heart failure and in predisposing conditions.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Climate Change and Cardiovascular Risk Factors Management: Emerging Challenges and Strategies for Prevention and Adaptation.

European journal of preventive cardiology·2026
Same author

A natural experiment in the air: particulate matter and acute myocardial infarction subtypes during the COVID-19 pandemic.

European heart journal·2026
Same journal

Rethinking triglycerides in the management of ASCVD.

European journal of preventive cardiology·2026
Same journal

Mapping the continuum: polygenic risk of coronary artery disease.

European journal of preventive cardiology·2026
Same journal

Why is Transition so Relevant to Prevention in Congenital Heart Disease? Start Early, Educate, Empower Families and Patients.

European journal of preventive cardiology·2026
Same journal

Beyond Awareness and Diagnosis: From Knowledge to Action for Blood Pressure Control in Coronary Artery Disease.

European journal of preventive cardiology·2026
Same journal

Harmonica-based breathing exercises during hybrid cardiac telerehabilitation: a randomized controlled trial (HARMONY CR).

European journal of preventive cardiology·2026
Same journal

First count the particles: ApoB, the LDL-C/TC ratio, and the hierarchy of lipid risk assessment.

European journal of preventive cardiology·2026
See all related articles

Related Experiment Video

Updated: Aug 17, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.4K

Editorial comments: Focus on atherosclerosis

Geza Halasz1, Gianfranco Parati2, Massimo F Piepoli3,4

  • 1Azienda Ospedaliera San Camillo-Forlanini, circonvallazione Gianicolense, 87 00152 Rome, Italy.

European Journal of Preventive Cardiology
|December 13, 2022
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

13.9K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

37.9K

Related Experiment Videos

Last Updated: Aug 17, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.4K
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

13.9K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

37.9K